CRIS Chart
See on advanced chart >
About
Curis, Inc. were organized as a Delaware corporation in February 2000. The company is a biotechnology company focused on the development of emavusertib, an orally available, small molecule inhibitor of Interleukin-1 receptor associated kinase.
Read More
- HighlightA biotechnology company that developing innovative therapeutics for the treatment of cancer
- ExchangeNASDAQ
- Listing Date08/01/2000
- Established DateInvalid Date
- Full-time Employees48
- Address128 Spring Street Building C - Suite 500 Lexington Massachusetts 02421
- Tel1-617-5036500
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology